Catalyst Wire Dossier Catalyst Wire Dossier

Atropine (unspecified formulation)

atropine · LitePharmTech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atropine (unspecified formulation), covering 2023-02-23 to 2023-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Atropine Therapeutic Effect on Myopic Progression [Phase 3]

See pricing